FPT Retail (FRT): Long Chau Expands Santen Eye-Care Partnership in Vietnam

Overview

Long Chau, the pharmacy and vaccination chain owned by FPT Retail (FRT, HOSE), announced an expanded strategic partnership with Japan’s Santen Pharmaceutical, aimed at building a more comprehensive eye-care journey for Vietnamese patients. The announcement was timed to World Sight Day on 8 October and was presented at a ceremony attended by senior leadership from both companies. For FRT, the deal reinforces the healthcare-services layer that sits alongside its core FPT Shop retail business.

Key Facts

• Santen brings 136 years of ophthalmology experience to the partnership, per company statements at the announcement event.
• Long Chau’s pharmacy and vaccination network covers 34 provinces and cities across Vietnam.
• The ceremony was attended by Tomoyuki Yoshida, General Director of Santen Asia, and Nguyen Minh Phuc, General Director of Santen Vietnam.
• Nguyen Do Quyen, Deputy General Director of FPT Retail and CEO of the Long Chau pharmacy and vaccination system, represented FRT at the event.
• The scope covers eye-care and vision-protection programmes plus improved access to treatment for eye conditions.
• The announcement was tied to World Sight Day, 8 October.
• No contract value, revenue target, or exclusivity terms were disclosed in the source article.

What Happened

According to the companies’ joint announcement, Long Chau and Santen will roll out community eye-care and vision-protection programmes in Vietnam, combining Santen’s ophthalmology portfolio with Long Chau’s community pharmacy footprint. The two sides framed the collaboration as a step from reactive treatment toward more proactive and sustained eye health, with Long Chau positioning itself as the “first healthcare touchpoint” for patients.

Yoshida said the agreement marks an important milestone in the relationship between the two parties and reflects a shared commitment to improving eye health in Vietnam, adding that Vietnam remains an important market for Santen. Quyen cited Long Chau’s nationwide network and medical staffing as the platform for delivering the programmes. The article does not disclose the transaction value, the duration of the agreement, or any specific product or revenue commitments.

Market Context

FRT closed at VND 147,000 on 30 September 2026. The stock trades on HOSE, where FPT Retail sits in the retail sector but increasingly derives its growth narrative from Long Chau’s pharmacy and vaccination operations rather than consumer electronics. The partnership lands in a Vietnamese healthcare-retail segment that has drawn sustained interest from foreign pharmaceutical and device makers seeking distribution reach, and it aligns with the broader Vietnam-Japan cooperation theme in healthcare and technology referenced in the announcement.

Strategic Significance

The strategic thesis for FRT rests on converting Long Chau from a dispensing network into a healthcare platform with higher-margin services and stronger supplier leverage. Partnering with an established Japanese ophthalmology specialist gives Long Chau differentiated product access and clinical credibility in a category where Vietnamese patients often self-medicate or delay specialist care. If executed, this deepens FRT’s moat against other pharmacy chains and pure-play e-commerce competitors, and it creates a template for similar category partnerships in other therapeutic areas. The absence of disclosed financial terms means the near-term earnings contribution cannot be modelled from this announcement alone.

What to Watch

• FRT’s next quarterly earnings release for Long Chau revenue growth and pharmacy store count.
• Any disclosure of contract duration, product exclusivity, or revenue-sharing terms with Santen.
• Expansion of the eye-care programme beyond the initial 34-province footprint.
• Follow-on category partnerships between Long Chau and other multinational pharmaceutical manufacturers.
• Vietnamese regulatory developments on pharmacy-chain operations and prescription drug distribution.